Navigation Links
ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
Date:12/9/2009

ADDISON, Texas, Dec. 9 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced today that a presentation on Altrazeal(TM) Transforming Powder Dressing will be made at the prestigious 10th Annual Wound Healing Science and Industry Conference to be held December 10-13, 2009 in St Thomas, U.S. Virgin Islands. The presentation will include research on advanced applications of Altrazeal(TM) related to the development of future products in drug delivery and tissue engineering. This conference is organized as a collaborative series of symposia and poster presentations with many of the top scientists and clinicians in the field of wound care discussing advanced research and treatments. Conference details and the program can be found at www.stthomaswoundhealing.com.

John V. St. John, PhD, Vice President of Research and Development for ULURU Inc., is part of a limited number of industry scientists who have been invited to make a podium presentation. The presentation to be made by Dr. St. John will detail the physical and chemical nature of Altrazeal(TM) and highlight the research performed at ULURU Inc. on the development of advanced products allowing controlled release of growth factors. Commenting on the meeting, Peter Sheehan, MD, a conference organizer, stated: "The meeting is a gathering of elite scientists and industry leaders to exchange ideas on new directions in the field of Wound Healing. It's really become the Davos of Wound Healing."

Renaat Van den Hooff, President and CEO of ULURU Inc., commented: "It is very prestigious for our company that Dr. St. John has been invited to participate in this leading symposium. I believe it is a tribute to the novelty of Altrazeal(TM) and the Nanoflex technology, and a recognition that Altrazeal(TM) has the potential to impact the way wounds will be more effectively treated in the future. We remain committed to the development of advanced therapies in wound healing and to the integration of the latest scientific advances into our future product development programs."

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex(TM) Aggregate technology and OraDisc(TM) transmucosal delivery system. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com/. For further information about Altrazeal(TM), please visit http://www.altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the effectiveness in wound healing of Altrazeal(TM). These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, and other reports filed by us with the Securities and Exchange Commission.


Contact: Company
----------------
Renaat Van den Hooff
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145

SOURCE ULURU Inc.


'/>"/>
SOURCE ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
2. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
3. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
4. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
5. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
6. Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora
7. Arpida Invited to Present Data on Iclaprim at Scientific Conference
8. Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting
9. Women Invited to Join New Health Registry to Advance Research
10. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
11. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... 20, 2017  Vivify Health, the pioneer and market ... awarded a very significant patent for the advancement of ... care via digital health.  This landmark patent provides the ... further secures Vivify,s position as the leader in remote ... the first company to apply consumer mobile devices, wireless ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
(Date:4/24/2017)... City, UT (PRWEB) , ... April 24, 2017 , ... ... efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable energy. ... remedy provider. They look to nature to find solutions for health issues, and maintain ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The bar for ... those unreal icons inhabiting the rarified air of pop and film stardom.(1) Not to ... anyone snapping pictures: the smile. Grins now run the gamut from being encrusted with ...
Breaking Medicine News(10 mins):